Adamis Pharmaceuticals Corporation

Adamis Pharmaceuticals Corporation is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. Adamis Pharmaceuticals Corporation is not very popular among insiders. Adamis Pharmaceuticals Corporation is a mediocre stock to choose.
Log in to see more information.
Adamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, develop...
ADMP Fundamental Data by TradingView

News

Adamis Pharmaceuticals Announces Closing of $8.0 Million Public Offering
Adamis Pharmaceuticals Announces Closing of $8.0 Million Public Offering

Globe Newswire SAN DIEGO, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced the closing of its public offering of...\n more…

Adamis Pharmaceuticals down after announcing pricing of $8M public offering
Adamis Pharmaceuticals down after announcing pricing of $8M public offering

Seeking Alpha - Healthcare Adamis Pharmaceuticals Corporation (ADMP) shares down 71% after it announced pricing of its public offering of 5,930,000 units at a price of $1.35 per unit.Each unit consists of one...\n more…

Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public Offering
Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public Offering

Globe Newswire SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation(NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced the pricing of its public offering of 5,930,000 units at a public offering price of $1.35 per unit. Each unit consists of one share of common ...\n more…

Why Aaron's Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Why Aaron's Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Benzinga Gainers Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) shares gained 188.8% to $4.13. The stock is now on the Regulation SHO "threshold security" list.\n more…

Adamis Pharmaceuticals Co. (NASDAQ:ADMP) Short Interest Update
Adamis Pharmaceuticals Co. (NASDAQ:ADMP) Short Interest Update

Zolmax Adamis Pharmaceuticals Co. (NASDAQ:ADMP Get Free Report) was the target of a large decline in short interest during the month of July. As of July 15th, there was short interest totalling 57,700 shares, a decline of 51.4% from the June 30th total of 118,700 shares. Based on an average trading volume ...\n more…

Adamis Pharmaceuticals to Fund ZIMHI Clinical Study with University of Leiden Opioid Expert
Adamis Pharmaceuticals to Fund ZIMHI Clinical Study with University of Leiden Opioid Expert

Globe Newswire SAN DIEGO, July 28, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced the Company has committed to fund an...\n more…